For many people, "protein" is the key element of a food order. However, beyond the preferred choice of meats or plant-based ...
Scalable, parallel drug design: one researcher can run multiple campaigns simultaneously across targets and modalities * From research goal to lab ...
"A new Pulse Report from BCC Research, AI Impact on Neuroprotective Agents, provides a comprehensive analysis of how AI is ...
Experts have been raising concerns about “AI washing.” One of these experts, futurist Bernard Marr, has said that AI washing “involves exaggerating the capabilities of a product or service that is ...
Recent developments in the biopharma AI world include a big financing for Verily, plus news from Zealand Pharma, Latent Labs, ...
Despite significant progress in medicinal chemistry and life sciences research, drug discovery and development remain slow and expensive, taking on average approximately 15 years and US$2 billion to ...
Google DeepMind announced the launch of AlphaProteo, an AI system to help biological and health researchers design novel, high-strength proteins that bind to target molecules with accuracy and ...
Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - November 9, 2023) - PurMinds NeuroPharma ("PurMinds™" or the "Company"), a clinical-stage neuroscience company focused on neurological and ...
SCIENTIFIC PAPERS are normally models of discreet understatement. They are also (or are at least supposed to be) loaded with the information needed for others to replicate their findings. Not this one ...
Explore the potential of light-driven chemistry to revolutionize drug design, making it safer and more efficient.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results